drugset / Trial / NCT01672645

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

NCT01672645 ↗

Phase 1 Completed 277 enrolled Pfizer
RandomizedQuadruple-blindTreatment

Summary

The purpose of this study is to determine the safety and tolerability of multiple doses of PF-05402536 and PF-06413367 in healthy adult smokers.

Timeline

Start
2012-06
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject NIC7-001 Unknown — Intramuscular
Subject NIC7-003 Unknown — Intramuscular

Indications

No indication recorded.